Jazz Pharmaceuticals Plc · NASDAQ:JAZZ
Iannone Robert sold 76,921 Jazz Pharmaceuticals Plc shares (Form 4)
Traded Aug 27, 2026 · Filed Aug 31, 2026
On Aug 27, 2026, Iannone Robert (EVP, Global Head of R&D & CMO) sold 76,921 Jazz Pharmaceuticals Plc shares at an average US$249.70 for US$19.2M under a trading plan, leaving 65,686 shares. Filed Aug 31, 2026 (Form 4).
- Sold
- 76,921 shares
- Price
- US$249.70 average (US$247.86 to US$252.76)
- Value
- US$19.2M
- Holding after
- 65,686 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Global Head of R&D & CMO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Ordinary Shares | Option exercise | 26,116 | US$113.10 | 111,223 | Direct |
| Aug 27, 2026 | Ordinary Shares | Option exercise | 884 | US$113.10 | 112,107 | Direct |
| Aug 27, 2026 | Ordinary Shares | Option exercise | 27,584 | US$137.12 | 139,691 | Direct |
| Aug 27, 2026 | Ordinary Shares | Option exercise | 2,916 | US$137.12 | 142,607 | Direct |
| Aug 27, 2026 | Ordinary Shares | Sale | 18,187 | US$247.86 | 124,420 | Direct |
| Aug 27, 2026 | Ordinary Shares | Sale | 11,423 | US$248.67 | 112,997 | Direct |
| Aug 27, 2026 | Ordinary Shares | Sale | 18,113 | US$250.02 | 94,884 | Direct |
| Aug 27, 2026 | Ordinary Shares | Sale | 19,639 | US$250.60 | 75,245 | Direct |
| Aug 27, 2026 | Ordinary Shares | Sale | 9,259 | US$251.95 | 65,986 | Direct |
| Aug 27, 2026 | Ordinary Shares | Sale | 300 | US$252.76 | 65,686 | Direct |
Source
Related
- Jazz Pharmaceuticals Plc
- Iannone Robert
- Jazz Pharmaceuticals Plc shareholders
- Form 4 · Iannone Robert · Jul 2, 2026
- Form 4 · Gala Renee D · Oct 7, 2026
- Form 4 · Cozadd Bruce C · Oct 5, 2026
- Form 4 · Patil Neena M · Sep 14, 2026
- Form 4 · Gala Renee D · Sep 10, 2026
- Form 4 · Henderson Mary Elizabeth · Sep 10, 2026